HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2249447Generated: October 29, 2026
1-Methylpiperazine → N-Desethyl-N-Methyl Vardenafil
https://huagongshe.com/reaction/2249447
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 1-Methylpiperazine | HCID 53167 | — |
| Reactant | 4-Ethoxy-3-(5-methyl-4-oxo-7-propyl-1,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl)benzene-1-sulfonyl chloride | HCID 135430159 | — |
| Catalyst | 4-(Dimethylamino)pyridine | HCID 14284 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | N-Desethyl-N-Methyl Vardenafil | HCID 135544141 | 88% |
Reaction Steps
1.23 g (3 mmol) of 4-ethoxy-3-(5-methyl-4-oxo-7-propyl-3,4-dihydro-imidazo[5,1-f][1,2,4]triazin-2-yl)-benzenesulphonyl chloride are dissolved in 40 ml of dichloromethane and cooled to 0° C. After addition of a spatula tip of DMAP, 0.90 g (9.00 mmol) of N-methylpiperazine are added, and the reaction mixture is stirred at room temperature overnight. The mixture is diluted with dichloromethane, the organic phase is washed twice with water and dried over sodium sulphate and the solvent is removed under reduced pressure. Crystallization from ether gives 1.25 g (88%) of a colourless solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07314871B2 |
|---|
| Source dataset | uspto-grants-2008_01 |
|---|
| ORD ID | ord-fda99c002964430fb3dce40f076f8932 |
|---|
| Source note | uspto-grants-2008_01 |
|---|